About Viraday Cipla Tablets
Find trending health solutions with Viraday Cipla Tablets, a paragon of antiretroviral therapy. Each excellent, film-coated yellow oval tablet contains Emtricitabine 200 mg, Tenofovir Disoproxil Fumarate 300 mg, and Efavirenz 600 mg, designed for flawless oral administration. Suitable for adults and adolescents above 12 years, Viraday offers effective HIV-1 infection management when used under strict medical supervision. Remember, this prescription-only, HDPE-packaged product from India delivers 30 tablets per bottle and must be stored below 30C. Add to Cart today to experience quality and assurance.
Exceptional Features and Targeted Usage
Viraday Cipla Tablets stand out for their extra features, including a convenient once-daily dosage and high-quality manufacturing as an allopathic, anti-HIV therapy. Flawlessly engineered in tablet form, they are recommended for adults and adolescents seeking precise HIV-1 management. The robust composition, superior film-coating, and patient-centered design sustain their paragon status in targeted antiretroviral treatment, making them an excellent choice on the market for those requiring specialized medication.
Packaging Details and Domestic Logistics
Packaged securely in HDPE bottles, each containing 30 tablets, Viraday is ideal for safe storage and easy dispatching. Supplying predominantly in the Indian domestic market, orders are typically processed based on a valid Purchase Order. Valuation may differ by region due to MRP variations, ensuring client-specific pricing. Prompt order dispatching and professional handling ensure timely delivery, making this product accessible for authorized buyers across India.
FAQ's of Viraday Cipla Tablets:
Q: How should Viraday Cipla Tablets be administered?
A: Viraday Cipla Tablets are designed for oral administration, typically taken once daily, as directed by your physician. Always follow your healthcare provider's instructions precisely.
Q: What are the main ingredients in Viraday Tablets?
A: The active ingredients per tablet include Emtricitabine 200 mg, Tenofovir Disoproxil Fumarate 300 mg, and Efavirenz 600 mg, offering a potent combination for anti-HIV therapy.
Q: When should Viraday Cipla Tablets not be used?
A: These tablets are contraindicated in individuals with known hypersensitivity to any of the listed components. Consult your healthcare provider before starting therapy.
Q: What potential side effects may occur with Viraday Tablets?
A: Some individuals may experience dizziness, nausea, headache, or rash. Report any severe or concerning symptoms to your physician promptly.
Q: Where should Viraday Tablets be stored?
A: Store Viraday Tablets in their original HDPE bottle below 30C, protected from moisture, and keep them out of reach of children.
Q: What is the benefit of using Viraday Tablets?
A: When prescribed for HIV-1 infection, Viraday offers a comprehensive and effective triple-drug regimen, supporting viral suppression and improved health outcomes for adults and adolescents.